Cardinal Health provides fiscal 2015 guidance after fiscal Q4 results

|About: Cardinal Health Inc. (CAH)|By:, SA News Editor

Cardinal Health (NYSE:CAH) fiscal Q4 and fiscal 2014 results:

Q4: Revenue: $22,894M (-9.9%), Pharmaceutical: $20,092M (-11.8%), Medical: $2,794M (+3.4%); Gross Margin: $1,256M (+0.7%); Operating Expenses: $795M (+2.6%); Operating Income: $387M (+180.8%); Net Income: $234M (+139.9%); EPS: $0.68 (+139.5%); Quick Assets: $2,865M (+50.7%); CF Ops: $716M (+138.7%).

Fiscal 2014: Revenue: $91,084 (-9.9%), Pharmaceutical: $80,110M (-12.1%), Medical: $10,962M (+9.0%); Gross Margin: $5,161M (+4.9%); Operating Expenses: $3,028M (+5.3%); Operating Income: $1,885M (+89.3%); Net Income: $1,166M (+249.1%); EPS: $3.38 (+248.5%).

Fiscal 2015 Guidance: non-GAAP EPS: $4.10 - 4.30.